Meanwhile, in RA patients, dopamine could activate the dopaminergic receptor (DR) and inhibit the release of IL-6, IL-8, and tumor necrosis factor (TNF) from synovial fibroblasts [61,62]. The gene discussed is TNF; the disease is rheumatoid arthritis.